Isis Pharmaceuticals Inc (NASDAQ:ISIS)

Data as of Jan 26
 +1.62 / +2.27%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues42.2M28.2M57.1M44.1M
Operating ExpensesGross Income----------
Total Operating Expenses62.1M57.8M63.7M65.6M
Non-Operating ExpensesOperating Income-19.9M-29.7M-6.7M-21.5M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.8M-33.6M-11.2M-25.3M
Income Taxes-523.0K-2.3M-881.0K-1.4M
Net Income-24.3M-31.3M-12.1M-26.7M
Shares To Calculate EPSShares To Calculate EPS116.1M117.1M117.6M117.8M
Shares To Calculate EPS Diluted116.1M117.1M117.6M117.8M
Earnings Per ShareEPS-$0.21-$0.27-$0.10-$0.23
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.